4
Changes in Ownership
Anixa Biosciences Inc Filed Acc 0001493152-22-006624
Options or other derivatives
- Chief Executive Officer acquired 500,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| KUMAR AMIT Chief Executive Officer | 2022-03-10 | Grant or award · Employee Stock Option (Right to Buy) | +500,000 | 500,000 | D: show line 1 in the form |
Loading xslF345X03/ownership.xml…